23
Views
46
CrossRef citations to date
0
Altmetric
Original Article

Substituent Effects in the Free Radical Reactions of Silybin: Radiation-induced Oxidation of the Flavonoid at Neutral pH

, , &
Pages 603-609 | Received 14 Oct 1991, Accepted 31 Dec 1991, Published online: 03 Jul 2009
 

Abstract

Silybin dihemisuccinate sodium salt, a flavonoid used in human therapy of liver dysfunction, has an inhibitory effect in vivo on radiation-induced deactivation of enzymes and peroxidation of membrane lipids in rat liver microsomes. The reactivity of silybin and its phenolic OH groups towards free radicals in aqueous solution was studied by pulse radiolysis. Absorption spectra for the phenoxyl-type radicals were assigned using structurally similar models. The one-electron reduction potential for silybin at pH 7 (E07 = 0·76 V), determined using the p-methoxy-phenoxyl/phenolate redox couple as reference standard (E07 = 0·72 V, Lind et al. 1990), is related to the 3′-methoxy-4′-OH structure, the exclusive target for one-electron oxidation at pH7, while the 7-OH and 5-OH groups are prevented from oxidation by 4-keto substitution and intramolecular H-bonding, respectively. The free radical reactivity of silybin compares favourably with poly-OH-substituted flavonoids; however, the latter compounds have been reported to generate potentially toxic oxygen species at a biologically relevant pH.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.